Assessment of the Products of Systemic Lupus Erythematosus (SLE) Genetic Predisposition Biomarkers in Bulgaria

The scope of the current clinical trial is to investigate the products of systemic lupus erythematosus (SLE) genetic predisposition biomarkers and to determine those biomarkers that correlate with the clinical course of the disease. The present study includes 48 patients with SLE (43 women and 5 men) age 53 years with 4.32 points (min. 0 max. 12 points) of activity of SLE be SLEDAI-2K and 35…